Navigation Links
Personalized Stem Cells, Inc. Announces First Patients Treated in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
Date:11/14/2019

Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has successfully enrolled the first patients in an FDA approved clinical trial for stem cell treatment of knee osteoarthritis. The first treatment came shortly after the one-year anniversary of the formation of the company as a subsidiary of VetStem Biopharma.

In July of 2019, PSC received FDA approval for a New Drug (IND) application to conduct clinical trials for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. This first clinical trial uses stem cells to treat osteoarthritis in the knee.

PSC has recruited, trained, and qualified clinical trial sites sufficient to treat up to 125 patients in this first clinical trial. Clinical trial sites are currently located in San Diego and Los Angeles California, Portland Oregon, Chicago Illinois, and New Jersey. Additional clinical trial sites are anticipated in coming months.

PSC CEO, Michael Dale, stated, “We are pleased with the response from patients who suffer from knee arthritis and with the diligence and enthusiasm of the participating clinics around the country. We expect to rapidly increase enrollment in this first clinical trial as we prepare for additional clinical trials using stem cells for orthopedic injuries.”

This is the first of several planned clinical trials which will enable qualified PSC-enrolled physicians to provide FDA compliant, quality cell therapy to patients suffering from osteoarthritis. PSC plans to conduct a series of FDA approved clinical trials starting with uses in orthopedics and expanding to other medical conditions such as trauma in the future.

PSC is working within the FDA cell therapy regulations to provide stem cell therapy for patients that follows the rules FDA has created in order to assure consistent manufacturing, quality tested cells and clinical trial and manufacturing oversite for safety and efficacy.

PSC was founded by Michael Dale, CEO, and Robert Harman, DVM, MPVM, Chief Scientific Officer, both of whom also co-founded VetStem Biopharma and are both experienced serial entrepreneurs.

About Personalized Stem Cells, Inc.
Personalized Stem Cells was formed in 2018 to advance and legitimize human regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), offers qualified physicians who enroll, an FDA compliant autologous stem cell product (from patient’s own fat tissue) for use in FDA approved clinical trials. PSC is driving development and adoption of stem cell and regenerative medicine within the FDA-IND process by providing cGMP manufactured, quality tested cells, and well-defined clinical trials. PSC has licensed a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/personalized_stem_cells_inc_announces_first_patients_treated_in_fda_approved_clinical_trial_for_treatment_of_osteoarthritis_with_stem_cells/prweb16717272.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Personalized Stem Cells, Inc. Announces First Patients Enrolled in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
2. VetStem Biopharma Secures FDA Approval of First Human IND for its Subsidiary, Personalized Stem Cells, Inc.
3. Personalized Stem Cells, Inc. Announces FDA Approval of IND Application for Treatment of Osteoarthritis with Stem Cells
4. Personalized Medicine: A New Approach to Treat Periodontal Diseases
5. Zipongo Incorporates 23andMe Reports Into Personalized Nutrition Plans
6. Personalized Medicine - Scientific and Commercial Aspects - 318 Companies Profiled with 575 Collaborations - Research and Markets
7. NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology
8. @USANAincs Personalized Nutrition Program Wins Industry Innovation Award
9. "Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014
10. Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers
11. Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2020)... ... 04, 2020 , ... Crystal Diagnostics (CDx) announced today that ... related to proprietary liquid crystal technology for rapid and accurate detection of foodborne ... on December 3, 2019. Together, these patents protect the company’s liquid crystal technology ...
(Date:2/1/2020)... ... 2020 , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each year in ... HCC is the 5th most common cancer and the 2nd leading cause of cancer ... incidence of HCC, while China has half of all patients suffering from liver cancer. ...
(Date:1/29/2020)... ... January 29, 2020 , ... ... Analytics and Data Sciences practice, providing consulting services for strategy, research and development ... by Mike Townley, co-founder and Managing Partner of CREO, an innovative management consulting ...
Breaking Biology News(10 mins):
(Date:2/10/2020)... ... 10, 2020 , ... R3 Medical Training announced it is now registering for ... Vegas. The course is hands on involving real patients and stem cell biologics, with ... Comprehensive Stem Cell Training Course has received rave reviews from attendees, who love the ...
(Date:2/3/2020)... ... February 03, 2020 , ... ... MA, announce that OmniType, the 11-locus, single tube multiplex successor to Holotype HLA ... best-in-class product featuring locus-multiplexing and short library preparation, for HLA genotyping from sample ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, the leader in “instant ... today announced the availability of neuroscience of transformational leadership workshops. These highly interactive, ... of leadership and change research to become great transformational leaders. The workshops ...
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra Instruments, global leader in ... controllers ideal for BioPharm OEMS. Sierra also announces RedyCompact™ flow ... instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an advanced, ultra-stable no-drift ...
Breaking Biology Technology: